Adaptive Biotechnologies (ADPT) Profit After Tax (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Profit After Tax data on file, last reported at -$20.0 million in Q1 2026.

• Quarterly Profit After Tax rose 32.95% year-over-year to -$20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.7 million (up 65.0% YoY) and the FY2025 annual result came in at -$59.5 million, up 62.72% from the prior year.
• Profit After Tax fell to -$20.0 million in Q1 2026 per ADPT's latest filing, from -$13.6 million in the prior quarter.
• The five-year high for Profit After Tax was $9.5 million in Q3 2025, with the low at -$69.4 million in Q4 2023.
• Average Profit After Tax over 5 years is -$39.1 million, with a median of -$45.3 million recorded in 2022.
• Year-over-year, Profit After Tax plunged 72.29% in 2023 and jumped 129.74% in 2025.
• Adaptive Biotechnologies' Profit After Tax stood at -$40.3 million in 2022, then sank by 72.29% to -$69.4 million in 2023, then surged by 51.33% to -$33.8 million in 2024, then surged by 59.7% to -$13.6 million in 2025, then plunged by 46.94% to -$20.0 million in 2026.
• Business Quant data shows ADPT's Profit After Tax at -$20.0 million in Q1 2026, -$13.6 million in Q4 2025, and $9.5 million in Q3 2025.